skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Construction and Evaluation of Novel Rhesus Monkey Adenovirus Vaccine Vectors

Journal Article · · Journal of Virology
DOI:https://doi.org/10.1128/JVI.02950-14· OSTI ID:1235731
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [3];  [3];  [3];  [4];  [5]
  1. Harvard Medical School, Boston, MA (United States)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  3. Washington Univ. School of Medicine, St. Louis, MO (United States)
  4. Los Alamos National Laboratory
  5. Harvard Medical School, Boston, MA (United States); Ragon Inst. of MGH, Boston, MA (United States)
+ Show Author Affiliations

Adenovirus vectors are widely used as vaccine candidates for a variety of pathogens, including HIV-1. To date, human and chimpanzee adenoviruses have been explored in detail as vaccine vectors. Furthermore, the phylogeny of human and chimpanzee adenoviruses is overlapping, and preexisting humoral and cellular immunity to both are exhibited in human populations worldwide. More distantly related adenoviruses may therefore offer advantages as vaccine vectors. We describe the primary isolation and vectorization of three novel adenoviruses from rhesus monkeys. The seroprevalence of these novel rhesus monkey adenovirus vectors was extremely low in sub-Saharan Africa human populations, and these vectors proved to have immunogenicity comparable to that of human and chimpanzee adenovirus vaccine vectors in mice. These rhesus monkey adenoviruses phylogenetically clustered with the poorly described adenovirus species G and robustly stimulated innate immune responses. These novel adenoviruses represent a new class of candidate vaccine vectors.

Research Organization:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC52-06NA25396
OSTI ID:
1235731
Report Number(s):
LA-UR-14-28201
Journal Information:
Journal of Virology, Vol. 89, Issue 3; ISSN 0022-538X
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 36 works
Citation information provided by
Web of Science

References (48)

Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes journal August 2012
Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector journal January 2012
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine journal November 2013
Induction of HIV-1–Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans journal August 2014
Chimpanzee-origin adenovirus vectors as vaccine carriers journal December 2005
Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors journal November 2003
Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae journal August 2010
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials journal January 2010
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys journal October 2013
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations journal July 2011
Intertypic modular exchanges of genomic segments by homologous recombination at universally conserved segments in human adenovirus species D journal August 2014
A Novel Complex Recombinant Form of Type 48-Related Human Adenovirus Species D Isolated in Japan journal January 2014
Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys journal July 2012
Isolation and Characterization of Adenoviruses Persistently Shed from the Gastrointestinal Tract of Non-Human Primates journal July 2009
Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events journal September 2013
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species journal January 2012
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments journal March 2010
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8 + T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization journal February 2013
Adenovirus Receptors journal September 2005
A Human Type 5 Adenovirus-Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity journal October 2013
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001) journal November 2012
First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001) journal November 2012
Development of a Targeted Gene Vector Platform Based on Simian Adenovirus Serotype 24 journal July 2010
The Canarypox Virus Vector ALVAC Induces Distinct Cytokine Responses Compared to the Vaccinia Virus-Based Vectors MVA and NYVAC in Rhesus Monkeys journal November 2013
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability journal January 2013
Comparative Seroprevalence and Immunogenicity of Six Rare Serotype Recombinant Adenovirus Vaccine Vectors from Subgroups B and D journal February 2007
Construction of the vector based on the CELO avian adenovirus genome providing enhanced expression of gene of secreted alkaline phosphatase in nonpermissive system in vitro and on vivo journal December 2008
Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys journal July 2012
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity journal October 2006
Protection of non-human primates against rabies with an adenovirus recombinant vaccine journal February 2014
Increased Mucosal CD4+ T Cell Activation in Rhesus Macaques following Vaccination with an Adenoviral Vector journal May 2014
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity journal May 2004
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity journal July 2012
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial journal November 2008
A Computer Program Designed to Screen Rapidly for HIV Type 1 Intersubtype Recombinant Sequences journal November 1995
Pathogenic Simian Immunodeficiency Virus Infection Is Associated with Expansion of the Enteric Virome journal October 2012
Molecular evolution of human adenoviruses journal May 2013
Creation of a panel of vectors based on ape adenovirus isolates journal December 2010
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys journal January 2012
Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity journal August 2003
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man journal January 2012
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys journal November 2010
Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus journal March 2013
Modulation of DNA Vaccine-Elicited CD8+ T-Lymphocyte Epitope Immunodominance Hierarchies journal September 2006
T cells induced by recombinant chimpanzee adenovirus alone and in prime-boost regimens decrease chimeric EcoHIV/NDK challenge virus load: Immunity to infection journal October 2012
Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials journal April 2013
The prevalence of neutralising antibodies to chimpanzee adenovirus type 6 and type 7 in healthy adult volunteers, patients with chronic hepatitis B and patients with primary hepatocellular carcinoma in China journal September 2013
Replication-Defective Bovine Adenovirus Type 3 as an Expression Vector journal November 1999

Cited By (7)

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination journal February 2017
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys journal August 2016
The Coxsackievirus and Adenovirus Receptor, a Required Host Factor for Recovirus Infection, Is a Putative Enteric Calicivirus Receptor journal September 2019
Comparative Evaluation of the Vaccine Efficacies of Three Adenovirus-Based Vector Types in the Friend Retrovirus Infection Model journal August 2019
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage journal January 2018
Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice journal January 2018
Development of Zika Virus Vaccines journal January 2018

Similar Records

An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
Journal Article · Tue Feb 12 00:00:00 EST 2013 · Virology Journal · OSTI ID:1235731
+12 more
Protection of non-human primates against rabies with an adenovirus recombinant vaccine
Journal Article · Sat Feb 15 00:00:00 EST 2014 · Virology · OSTI ID:1235731
Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques
Journal Article · Tue Jan 20 00:00:00 EST 2009 · Virology · OSTI ID:1235731
+8 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES